Regulation of MAP kinases by docking domains
暂无分享,去创建一个
[1] T. Toda,et al. The MAPK kinase Pek1 acts as a phosphorylation-dependent molecular switch , 1999, Nature.
[2] H. Enslen,et al. Growth Regulation via p38 Mitogen-activated Protein Kinase in Developing Liver* , 2000, The Journal of Biological Chemistry.
[3] A. Brunet,et al. Identification of MAP Kinase Domains by Redirecting Stress Signals into Growth Factor Responses , 1996, Science.
[4] Shuang Huang,et al. Induction of Apoptosis by SB202190 through Inhibition of p38β Mitogen-activated Protein Kinase* , 1998, Journal of Biological Chemistry.
[5] S. Keyse. Protein phosphatases and the regulation of MAP kinase activity. , 1998, Seminars in cell & developmental biology.
[6] M. Mock,et al. Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. , 2000, The Biochemical journal.
[7] A. Porras,et al. p38 MAP kinases: beyond the stress response. , 2000, Trends in biochemical sciences.
[8] R. Seger,et al. Altered Regulation of ERK1b by MEK1 and PTP-SL and Modified Elk1 Phosphorylation by ERK1b Are Caused by Abrogation of the Regulatory C-terminal Sequence of ERKs* , 2001, The Journal of Biological Chemistry.
[9] H. Rubinfeld,et al. Identification of a Cytoplasmic-Retention Sequence in ERK2* , 1999, The Journal of Biological Chemistry.
[10] M. Wilkinson,et al. Pyp1 and Pyp2 PTPases dephosphorylate an osmosensing MAP kinase controlling cell size at division in fission yeast. , 1995, Genes & development.
[11] R. Davis,et al. Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.
[12] C. Widmann,et al. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. , 1999, Physiological reviews.
[13] A. Brunet,et al. Substrate Recognition Domains within Extracellular Signal-regulated Kinase Mediate Binding and Catalytic Activation of Mitogen-activated Protein Kinase Phosphatase-3* , 2000, The Journal of Biological Chemistry.
[14] E. Nishida,et al. Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase , 1997, The EMBO journal.
[15] M. Gaestel,et al. Leptomycin B‐sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation , 1998, The EMBO journal.
[16] C. Tournier,et al. The MKK7 Gene Encodes a Group of c-Jun NH2-Terminal Kinase Kinases , 1999, Molecular and Cellular Biology.
[17] C. Marshall,et al. The sevenmaker gain‐of‐function mutation in p42 MAP kinase leads to enhanced signalling and reduced sensitivity to dual specificity phosphatase action , 1994, FEBS letters.
[18] Jiahuai Han,et al. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms , 1995, Science.
[19] Roger J. Davis,et al. The JIP Group of Mitogen-Activated Protein Kinase Scaffold Proteins , 1999, Molecular and Cellular Biology.
[20] Mutsuhiro Takekawa,et al. Protein phosphatase 2Cα inhibits the human stress‐responsive p38 and JNK MAPK pathways , 1998, The EMBO journal.
[21] R. Flavell,et al. Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[22] E. Nishida,et al. Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions , 2001, The EMBO journal.
[23] J. Wilsbacher,et al. The N-terminal ERK-binding Site of MEK1 Is Required for Efficient Feedback Phosphorylation by ERK2 in Vitro and ERK Activation in Vivo * , 1999, The Journal of Biological Chemistry.
[24] K. Irie,et al. Purification and Identification of a Major Activator for p38 from Osmotically Shocked Cells , 1996, The Journal of Biological Chemistry.
[25] P. Cohen,et al. Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines , 1995, Current Biology.
[26] W. Kolch. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. , 2000, The Biochemical journal.
[27] K D Paull,et al. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. , 1998, Science.
[28] Philip R. Cohen,et al. The development and therapeutic potential of protein kinase inhibitors. , 1999, Current opinion in chemical biology.
[29] H. Enslen,et al. T Cells + but Not CD 4 + Apoptosis of CD 8 Kinase In Vivo Selectively Induces Activation of p 38 Mitogen-Activated Protein , 1999 .
[30] Jonathan A. Cooper,et al. Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells. , 1992, The Journal of biological chemistry.
[31] Philip R. Cohen,et al. Activation of the novel stress‐activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases , 1997, The EMBO journal.
[32] H. Schaeffer,et al. Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers , 1999, Molecular and Cellular Biology.
[33] Cesare Montecucco,et al. Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNγ‐induced release of NO and TNFα , 1999 .
[34] E. Nishida,et al. A conserved docking motif in MAP kinases common to substrates, activators and regulators , 2000, Nature Cell Biology.
[35] L. Bardwell,et al. A conserved motif at the amino termini of MEKs might mediate high-affinity interaction with the cognate MAPKs. , 1996, Trends in biochemical sciences.
[36] Roger J. Davis,et al. Selective Activation of p38 Mitogen-activated Protein (MAP) Kinase Isoforms by the MAP Kinase Kinases MKK3 and MKK6* , 1998, The Journal of Biological Chemistry.
[37] H. Schaeffer,et al. MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. , 1998, Science.
[38] Jiahuai Han,et al. Selective Activation of p38a and p38g by Hypoxia ROLE IN REGULATION OF CYCLIN D1 BY HYPOXIA IN PC12 CELLS* , 1999 .
[39] E. Goldsmith,et al. Contributions of the Mitogen-activated Protein (MAP) Kinase Backbone and Phosphorylation Loop to MEK Specificity* , 1996, The Journal of Biological Chemistry.
[40] Robert J. Lefkowitz,et al. Identification of a Motif in the Carboxyl Terminus of β-Arrestin2 Responsible for Activation of JNK3* , 2001, The Journal of Biological Chemistry.
[41] M. Su,et al. Interferon‐γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway , 1998, The EMBO journal.
[42] E. Reddy,et al. Signaling by dual specificity kinases , 1998, Oncogene.
[43] G. Tsujimoto,et al. Parallel Regulation of Mitogen-activated Protein Kinase Kinase 3 (MKK3) and MKK6 in Gq-signaling Cascade* , 2001, The Journal of Biological Chemistry.
[44] E. Goldsmith,et al. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation , 1998, Current Biology.
[45] J. Gutkind,et al. Regulation of gene expression by the small GTPase Rho through the ERK6 (p38γ) MAP kinase pathway , 2001 .
[46] A. Brunet,et al. Nuclear translocation of p42/p44 mitogen‐activated protein kinase is required for growth factor‐induced gene expression and cell cycle entry , 1999, The EMBO journal.
[47] D. Lawrence,et al. Multiple Regions of MAP Kinase Phosphatase 3 Are Involved in Its Recognition and Activation by ERK2* , 2001, The Journal of Biological Chemistry.
[48] A. Ullrich,et al. PTP‐SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal‐regulated kinases ERK1 and ERK2 by association through a kinase interaction motif , 1998, The EMBO journal.
[49] Jiahuai Han,et al. BMK1/ERK5 regulates serum‐induced early gene expression through transcription factor MEF2C , 1997, The EMBO journal.
[50] E. Goldsmith,et al. Dimerization in MAP-kinase signaling. , 2000, Trends in biochemical sciences.
[51] Jiahuai Han,et al. Cardiac Hypertrophy Induced by Mitogen-activated Protein Kinase Kinase 7, a Specific Activator for c-Jun NH2-terminal Kinase in Ventricular Muscle Cells* , 1998, The Journal of Biological Chemistry.
[52] T. Maeda,et al. Activation of yeast PBS2 MAPKK by MAPKKKs or by binding of an SH3-containing osmosensor. , 1995, Science.
[53] M. Assanah,et al. Biochemical and Biological Functions of the N-Terminal, Noncatalytic Domain of Extracellular Signal-Regulated Kinase 2 , 2001, Molecular and Cellular Biology.
[54] E. Nishida,et al. A Novel Regulatory Mechanism in the Mitogen-activated Protein (MAP) Kinase Cascade , 1997, The Journal of Biological Chemistry.
[55] I. Ota,et al. Two Protein-tyrosine Phosphatases Inactivate the Osmotic Stress Response Pathway in Yeast by Targeting the Mitogen-activated Protein Kinase, Hog1* , 1997, The Journal of Biological Chemistry.
[56] P. Cohen,et al. The search for physiological substrates of MAP and SAP kinases in mammalian cells. , 1997, Trends in cell biology.
[57] M. Cobb,et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. , 2001, Endocrine reviews.
[58] R. Flavell,et al. Activation of the p38 Mitogen-Activated Protein Kinase Pathway Arrests Cell Cycle Progression and Differentiation of Immature Thymocytes in Vivo , 2000, The Journal of experimental medicine.
[59] N. Ahn,et al. Nuclear Localization of Mitogen-activated Protein Kinase Kinase 1 (MKK1) Is Promoted by Serum Stimulation and G2-M Progression , 1999, The Journal of Biological Chemistry.
[60] C. Marshall,et al. Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2 , 1998, Current Biology.
[61] M. Karin,et al. Mammalian MAP kinase signalling cascades , 2001, Nature.
[62] R. Davis,et al. MAPKs: new JNK expands the group. , 1994, Trends in biochemical sciences.
[63] A. Sharrocks,et al. Docking domains and substrate-specificity determination for MAP kinases. , 2000, Trends in biochemical sciences.
[64] M Dickens,et al. Interaction of a Mitogen-Activated Protein Kinase Signaling Module with the Neuronal Protein JIP3 , 2000, Molecular and Cellular Biology.
[65] M. Muda,et al. The Mitogen-activated Protein Kinase Phosphatase-3 N-terminal Noncatalytic Region Is Responsible for Tight Substrate Binding and Enzymatic Specificity* , 1998, The Journal of Biological Chemistry.
[66] E. Nishida,et al. Nuclear Export of Map Kinase (ERK) Involves a Map Kinase Kinase (Mek-Dependent) Active Transport Mechanism , 2000, The Journal of cell biology.
[67] M. Gabrielsen,et al. Distinct Binding Determinants for ERK2/p38α and JNK MAP Kinases Mediate Catalytic Activation and Substrate Selectivity of MAP Kinase Phosphatase-1* 210 , 2001, The Journal of Biological Chemistry.
[68] T. Hunter,et al. Signaling—2000 and Beyond , 2000, Cell.
[69] H. Enslen,et al. Molecular determinants that mediate selective activation of p38 MAP kinase isoforms , 2000, The EMBO journal.
[70] R. Davis,et al. Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals. , 1998, Trends in biochemical sciences.
[71] C. Der,et al. The Mitogen-activated Protein Kinase Phosphatases PAC1, MKP-1, and MKP-2 Have Unique Substrate Specificities and Reduced Activity in Vivo toward the ERK2 sevenmaker Mutation (*) , 1996, The Journal of Biological Chemistry.
[72] T. Mustelin,et al. Negative Regulation of T Cell Antigen Receptor Signal Transduction by Hematopoietic Tyrosine Phosphatase (HePTP)* , 1998, The Journal of Biological Chemistry.
[73] Jiahuai Han,et al. Characterization of the Structure and Function of a Novel MAP Kinase Kinase (MKK6) (*) , 1996, The Journal of Biological Chemistry.
[74] A. Brunet,et al. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts , 1993, The Journal of cell biology.
[75] Jiahuai Han,et al. Selective activation of p38alpha and p38gamma by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells. , 1999, The Journal of biological chemistry.
[76] Masahiko Watanabe,et al. MKP-7, a Novel Mitogen-activated Protein Kinase Phosphatase, Functions as a Shuttle Protein* , 2001, The Journal of Biological Chemistry.
[77] G. V. Vande Woude,et al. Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[78] M. Karin,et al. JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension. , 1998, Genes & development.
[79] E. Hafen,et al. A gain-of-function mutation in Drosophila MAP kinase activates multiple receptor tyrosine kinase signaling pathways , 1994, Cell.
[80] M. Cobb,et al. The Mitogen-Activated Protein Kinase p38-2 Is Necessary for the Inhibition of N-Type Calcium Current by Bradykinin , 1998, The Journal of Neuroscience.
[81] A. Ashworth,et al. MKP5, a new member of the MAP kinase phosphatase family, which selectively dephosphorylates stress-activated kinases , 1999, Oncogene.
[82] E. Nishida,et al. Cytoplasmic Localization of Mitogen-activated Protein Kinase Kinase Directed by Its NH2-terminal, Leucine-rich Short Amino Acid Sequence, Which Acts as a Nuclear Export Signal* , 1996, The Journal of Biological Chemistry.
[83] M. Gorospe,et al. Discordance between the Binding Affinity of Mitogen-activated Protein Kinase Subfamily Members for MAP Kinase Phosphatase-2 and Their Ability to Activate the Phosphatase Catalytically* , 2001, The Journal of Biological Chemistry.
[84] Carmen Blanco-Aparicio,et al. A Novel Regulatory Mechanism of Map Kinases Activation and Nuclear Translocation Mediated by Pka and the Ptp-Sl Tyrosine Phosphatase , 1999, The Journal of cell biology.
[85] T. Pawson,et al. Protein-protein interactions define specificity in signal transduction. , 2000, Genes & development.
[86] R. Davis,et al. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway , 1996, Molecular and cellular biology.
[87] R. Davis,et al. Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus , 1993, The Journal of cell biology.
[88] J. Blenis,et al. Nuclear localization and regulation of erk- and rsk-encoded protein kinases , 1992, Molecular and cellular biology.
[89] M. Muda,et al. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. , 1998, Science.
[90] Norinobu M. Watanabe,et al. The Ste20 group kinases as regulators of MAP kinase cascades. , 2001, Trends in cell biology.
[91] J. Ninomiya-Tsuji,et al. Regulation of the TAK1 Signaling Pathway by Protein Phosphatase 2C* , 2001, The Journal of Biological Chemistry.
[92] M. Camps,et al. Dual specificity phosphatases: a gene family for control of MAP kinase function , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[93] T. Maeda,et al. Regulation of the Saccharomyces cerevisiae HOG1 mitogen-activated protein kinase by the PTP2 and PTP3 protein tyrosine phosphatases , 1997, Molecular and cellular biology.
[94] R. Lefkowitz,et al. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. , 2000, Science.
[95] E. Nishida,et al. Two co‐existing mechanisms for nuclear import of MAP kinase: passive diffusion of a monomer and active transport of a dimer , 1999, The EMBO journal.
[96] S. Kassis,et al. SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. , 2001, The Journal of pharmacology and experimental therapeutics.
[97] Jiahuai Han,et al. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. , 2000, Genes & development.
[98] J Ross,et al. Cardiac Muscle Cell Hypertrophy and Apoptosis Induced by Distinct Members of the p38 Mitogen-activated Protein Kinase Family* , 1998, The Journal of Biological Chemistry.
[99] M. Cobb,et al. Hydrophobic as Well as Charged Residues in Both MEK1 and ERK2 Are Important for Their Proper Docking* , 2001, The Journal of Biological Chemistry.
[100] Robert J. Lefkowitz,et al. Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[101] E. Nishida,et al. A Novel MAPK Phosphatase MKP-7 Acts Preferentially on JNK/SAPK and p38α and β MAPKs* , 2001, The Journal of Biological Chemistry.
[102] E. Goldsmith,et al. Phosphorylation of MAP Kinases by MAP/ERK Involves Multiple Regions of MAP Kinases* , 1999, The Journal of Biological Chemistry.
[103] Y. Yanagawa,et al. Selective suppression of stress‐activated protein kinase pathway by protein phosphatase 2C in mammalian cells , 1998, FEBS letters.
[104] B. Cairns,et al. Signaling in the yeast pheromone response pathway: specific and high-affinity interaction of the mitogen-activated protein (MAP) kinases Kss1 and Fus3 with the upstream MAP kinase kinase Ste7 , 1996, Molecular and cellular biology.
[105] J. Yasuda,et al. A mammalian scaffold complex that selectively mediates MAP kinase activation. , 1998, Science.
[106] L. Flatauer,et al. A Conserved Docking Site in MEKs Mediates High-affinity Binding to MAP Kinases and Cooperates with a Scaffold Protein to Enhance Signal Transmission* , 2001, The Journal of Biological Chemistry.
[107] P. Cohen,et al. Stress-activated Protein Kinase-2/p38 and a Rapamycin-sensitive Pathway Are Required for C2C12 Myogenesis* , 1999, The Journal of Biological Chemistry.
[108] Philip R. Cohen,et al. SKK4, a novel activator of stress‐activated protein kinase‐1 (SAPK1/JNK) , 1997, FEBS letters.
[109] R. Flavell,et al. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. , 2001, Genes & development.